Thymosin β4 expression reveals intriguing similarities between fetal and cancer cells

Annals of the New York Academy of Sciences

Volumn 1269, Issue 1, 2012, Pages 53-60

  Faa, Gavino ^a   Nemolato, Sonia ^a   Cabras, Tiziana ^b   Fanni, Daniela ^a   Gerosa, Clara ^a   Fanari, Mattia ^a   Locci, Annalisa ^a   Fanos, Vassilios ^b   Messana, Irene ^b   Castagnola, Massimo ^c  

^a University Hospital San Giovanni di Dio   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cancer; Development; Embryogenesis; Immunohistochemistry; Thymosin beta 4

Indexed keywords

INTERLEUKIN 8; THYMOSIN BETA4; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL MATURATION; DOWN REGULATION; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; FETUS DEVELOPMENT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SALIVARY GLAND;

EID: 84867347150     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06679.x     Document Type: Article

References (61)

1. Goldstein, A.L., F.D. Slater & A. White 1966. Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc. Natl. Acad. Sci. U. S. A. 56: 1010-1017.
2. Low, T.L., S.K. Hu & A.L. Goldstein 1981. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc. Natl. Acad. Sci. U. S. A. 78: 1162-1166.
3. Yang, S.P., H.J. Lee & Y. Su 2005. Molecular cloning and structural characterization of the functional human thymosin beta4 gene. Mol. Cell. Biochem. 272: 97-105.
4. Filipowicz, A.W. & B.L. Horecker 1983. In vitro synthesis of thymosin beta 4 encoded by rat spleen mRNA. Proc. Natl. Acad. Sci. U. S. A 80: 1811-1815.
5. Hannappel, E. 2010. Thymosin beta4 and its posttranslational modifications. Ann. N. Y. Acad. Sci. 1194: 27-35.
6. Goldstein, A.L. et al 2012. Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin. Biol. Ther 12: 37-51.
7. Hannappel, E. 2007. beta-Thymosins. Ann. N. Y. Acad. Sci. 1112: 21-37.
8. Sanders, M.C., A.L. Goldstein & Y.L. Wang 1992. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc. Natl. Acad. Sci. U. S. A. 89: 4678-4682.
9. Sosne, G. et al 2010. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 24: 2144-2151.
10. Koutrafouri, V. et al 2001. Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. Biochim. Biophys. Acta 1568: 60-66.
11. Malinda, K.M. et al 1999. Thymosin beta4 accelerates wound healing. J. Invest. Dermatol 113: 364-368.
12. Badamchian, M. et al 2003. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int. Immunopharmacol 3: 1225-1233.
13. Bock-Marquette, I. et al 2004. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432: 466-472.
14. Huff, T., C.S. Muller & E. Hannappel 2007. Thymosin beta4 is not always the main beta-thymosin in mammalian platelets. Ann. N. Y. Acad. Sci. 1112: 451-457.
15. Gerosa, C. et al 2010. Thymosin beta-10 expression in developing human kidney. J. Matern. Fetal. Neonatal Med. 23(Suppl. 3): 125-128.
16. Fanni, D. et al 2011. Thymosin beta 10 expression in developing human salivary glands. Early Hum. Dev 87: 779-783.
17. Inzitari, R. et al 2009. HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). J. Sep. Sci 32: 57-63.
18. Nemolato, S. et al 2009. Thymosin beta(4) and beta(10) levels in pre-term newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development. PloS One 4: e5109.
19. Hay, E.D. 1995. An overview of epithelio-mesenchymal transformation. Acta Anat 154: 8-20.
20. Badamchian, M. et al 2007. Identification and quantification of thymosin beta4 in human saliva and tears. Ann. N. Y. Acad. Sci. 1112: 458-465.
21. Nemolato, S. et al 2010. Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells. Eur. J. Histochem 54: e3.
22. Larsson, L.I. & S. Holck 2007. Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment. Hum. Pathol. 38: 114-119.
23. Reti, R. et al 2008. Thymosin beta4 is cytoprotective in human gingival fibroblasts. Eur. J. Oral Sci 116: 424-430.
24. Sosne, G. et al 2002. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp. Eye Res 74: 293-299.
25. Smart, N., A. Rossdeutsch & P.R. Riley 2007. Thymosin beta4 and angiogenesis: modes of action and therapeutic potential. Angiogenesis 10: 229-241.
26. Goldstein, A.L. 2003. Thymosin beta4: a new molecular target for antitumor strategies. J. Natl. Cancer Inst. 95: 1646-1647.
27. Sun, H.Q., K. Kwiatkowska & H.L. Yin 1996. beta-Thymosins are not simple actin monomer buffering proteins. Insights from overexpression studies. J. Biol. Chem 271: 9223-9230.
28. Stossel, T.P., G. Fenteany & J.H. Hartwig 2006. Cell surface actin remodeling. J. Cell Sci 119: 3261-3264.
29. Philp, D., A.L. Goldstein & H.K. Kleinman 2004. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech. Ageing Dev. 125: 113-115.
30. Bonnet, D. et al 1996. Thymosin beta4, inhibitor for normal hematopoietic progenitor cells. Exp. Hematol 24: 776-782.
31. Moon, H.S. et al 2006. Zyxin is upregulated in the nucleus by thymosin beta4 in SiHa cells. Exp. Cell Res. 312: 3425-3431.
32. Sun, H.Q., H.L. Yin 2007. The beta-thymosin enigma. Ann. N. Y. Acad. Sci. 1112: 45-55.
33. Kupatt, C. et al 2005. Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J. 19: 1576-1578.
34. Nemolato, S. et al 2010. Different thymosin Beta 4 immunoreactivity in foetal and adult gastrointestinal tract. PloS One 5: e9111.
35. Nemolato, S. et al 2011. Expression pattern of thymosin beta 4 in the adult human liver. Eur. J. Histochem 55: e25.
36. Nemolato, S. et al 2012. Thymosin beta 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition. Cancer Biol. Ther 13: 191-197.
37. Levayer, R. & T. Lecuit 2008. Breaking down EMT. Nat. Cell Biol. 10: 757-759.
38. Nakaya, Y. et al 2008. RhoA and microtubule dynamics control cell-basement membrane interaction in EMT during gastrulation. Nat. Cell Biol 10: 765-775.
39. Siegrist, S.E. & C.Q. Doe 2007. Microtubule-induced cortical cell polarity. Genes Dev 21: 483-496.
40. Thiery, J.P. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol 15: 740-746.
41. Linker, C. et al 2005. beta-Catenin-dependent Wnt signalling controls the epithelial organisation of somites through the activation of paraxis. Development 132: 3895-3905.
42. Garber, K. 2008. Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J. Natl. Cancer Inst 100: 232-233.
43. Baum, B., J. Settleman & M.P. Quinlan 2008. Transitions between epithelial and mesenchymal states in development and disease. Semin. Cell Dev. Biol 19: 294-308.
44. Tse, J.C. & R. Kalluri 2007. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem. 101: 816-829.
45. Guarino, M., B. Rubino & G. Ballabio 2007. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39: 305-318.
46. Wang, Z.Y. et al 2012. Evaluation of thymosin beta4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Urol. Oncol 30: 167-176.
47. Wang, W.S. et al 2003. Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 22: 3297-3306.
48. Huang, H.C. et al 2007. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 26: 2781-2790.
49. Mannherz, H.G. & E. Hannappel 2009. The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family. Cell Motil. Cytoskeleton 66: 839-851.
50. Safer, D., R. Golla & V.T. Nachmias 1990. Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets. Proc. Natl. Acad. Sci. U. S. A. 87: 2536-2540.
51. Weber, A. et al 1992. Interaction of thymosin beta 4 with muscle and platelet actin: implications for actin sequestration in resting platelets. Biochemistry 31: 6179-6185.
52. Sosne, G. et al 2005. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest. Ophthalmol. Vis. Sci 46: 2388-2395.
53. Xu, G.J. et al 1982. Synthesis of thymosin beta 4 by peritoneal macrophages and adherent spleen cells. Proc. Natl. Acad. Sci. U. S. A. 79: 4006-4009.
54. Kannan, L. et al 2007. Identification and characterization of thymosin beta-4 in chicken macrophages using whole cell MALDI-TOF. Ann. N. Y. Acad. Sci. 1112: 425-434.
55. Naylor, P.H. et al 1984. Thymosin in the early diagnosis and treatment of high risk homosexuals and hemophiliacs with AIDS-like immune dysfunction. Ann. N. Y. Acad. Sci. 437: 88-99.
56. Hannappel, E. & M. van Kampen 1987. Determination of thymosin beta 4 in human blood cells and serum. J. Chromatogr 397: 279-285.
57. Cohen, M.V. & J.M. Downey 2008. Adenosine: trigger and mediator of cardioprotection. Basic Res. Cardiol 103: 203-215.
58. Young, J.D. et al 1999. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med 5: 1424-1427.
59. Nemolato, S. et al 2010. Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract. Eur. J. Histochem 54: e43.
60. Maulbecker, C.C. & P. Gruss 1993. The oncogenic potential of Pax genes. EMBO J. 12: 2361-2367.
61. Ozcan, A. et al 2011. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod. Pathol. 24: 751-764.